Navigation Links
HeartWare Schedules First Quarter Conference Call And Webcast
Date:4/15/2013

FRAMINGHAM, Mass. and SYDNEY, April 15, 2013 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR, ASX:HIN) has scheduled a conference call to discuss its financial results for the three months ended March 31, 2013, at 5:00 p.m. U.S. Eastern Daylight Time on Monday, April 29, 2013. The Company plans to release the financial results prior to the conference call.

The conference call with management will discuss the Company's financial results, highlights from the first quarter and business outlook.  The call may be accessed by dialing 1-877-941-4774 five minutes prior to the scheduled start time and referencing "HeartWare."  For callers outside the U.S., please dial +1-480-629-9760.

A live webcast of the call will also be available at the Company's website (www.heartware.com) by selecting "HeartWare First Quarter 2013 Conference Call" under the section titled "Corporate Presentations" on the Home Page.  A replay of the conference call will be available through the above weblink immediately following completion of the call.

A copy of the news release announcing results and related information will be available on the Company's website, www.heartware.com.

About HeartWare International

HeartWare International develops and manufactures miniaturized implantable heart pumps, or ventricular assist devices, to treat Class IIIB / IV patients suffering from advanced heart failure.  The HeartWare® Ventricular Assist System features the HVAD® pump, a small full-support circulatory assist device designed to be implanted next to the heart, avoiding the abdominal surgery generally required to implant competing devices.  The HeartWare System is approved in the United States for the intended use as a bridge to cardiac trans
'/>"/>

SOURCE HeartWare International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. HeartWare Stock Trading Halted Today; FDA Advisory Committee to Review HeartWare® Ventricular Assist System as a Bridge to Heart Transplantation
2. Heartware Schedules First Quarter Conference Call And Webcast
3. HeartWare Presentation at the Bank of America Merrill Lynch 2012 Health Care Conference to be Webcast
4. HeartWare Completes Enrollment In 450-Patient Pivotal Destination Therapy Clinical Trial
5. HeartWare International Receives CE Mark Addendum, Expanding Label to Include All Patients at Risk of Death From Refractory, End-Stage Heart Failure
6. HeartWare Names Peter F. McAree Chief Financial Officer
7. HeartWare Schedules Second Quarter Conference Call And Webcast
8. HeartWare Completes Acquisition Of World Heart Corporation
9. HeartWare Reports Second Quarter 2012 Results
10. HeartWare Presentation at the 2012 Wedbush PacGrow Lifesciences Management Access Conference to be Webcast
11. HeartWare Presentation At The Canaccord Genuity 32nd Annual Growth Conference To Be Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... N.C. , March 31, 2015 PGI ... capabilities in North America at ... facility. The anticipated plant expansion is centered ... a need for differentiated products for personal care product ... state-of-the-art printing capabilities with in-line slitting and packaging, will ...
(Date:3/31/2015)... Israel, March 31, 2015  Galmed Pharmaceuticals Ltd. ... company focused on the development and commercialization of ... liver diseases and cholesterol gallstones, today announced financial ... 2014. Fourth Quarter 2014 Highlights: ... a keynote address by Professor Rohit Loomba, MD, ...
(Date:3/31/2015)... , Mar. 27, 2015 Research and Markets ... addition of the "European Laboratory Information System ... by Type (Clinical Pathology Laboratory Information System, Anatomic ... report to their offering. The ... grow at a CAGR of 7.6% from 2014 ...
Breaking Medicine Technology:PGI Expands Manufacturing Capabilities At Mexico Plant 2Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 2Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 3Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 4Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 5Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 6Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 7Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 8European Laboratory Information System Market Report 2015: Germany holds a larger share of the laboratory information systems market 2European Laboratory Information System Market Report 2015: Germany holds a larger share of the laboratory information systems market 3
... Vista Partners announced today that it has updated coverage ... PRWP ) ("the Company") and maintains its twelve month target ... stated, "DAVANAT®, the Company,s lead product candidate, could potentially enhance ... Avastin® , while also reducing the side effect profile of ...
... Tenn. and MERCER ISLAND, Wash., Dec. 22, 2010 Renal ... to form the third largest provider of dialysis services in ...  The transaction – terms of which were not disclosed – ... 5,300 employees serving more than 19,000 patients in 260 locations ...
Cached Medicine Technology:Vista Partners Updates Coverage on Pro-Pharmaceuticals, Inc.; Maintains Target Price of $2.10 2Renal Advantage and Liberty Dialysis Deal Completed 2Renal Advantage and Liberty Dialysis Deal Completed 3
(Date:3/31/2015)... Stem cells may provide Crohn’s disease ... – fistulas – according to the results of a ... of STEM CELLS Translational Medicine (SCTM). After receiving an ... are collected from fat tissue, the fistulas in 75 ... eight weeks of their last treatment and remained so ...
(Date:3/31/2015)... 31, 2015 Diane Blackburn-Zambetti is ... the Mesothelioma Applied Research Foundation (Meso Foundation). Blackburn-Zambetti ... Your Health” at the BoRit Asbestos Superfund Citizen ... This program will discuss anatomy, six types of ... diseases, symptoms, treatments, prevention and proper communication with ...
(Date:3/31/2015)... PharmMD CEO Robert Yeager ... newly created, senior executive role of Chief Technology Officer ... delivery of high quality, efficient, reliable, and secure applications, ... momentum as a market innovator for Part D Star ... “We were very strategic in our search for the ...
(Date:3/31/2015)... Mega Photo, from the makers of Slidezilla, have created ... free app brings a new found life to photos and ... masterpieces. Mega Photo provides over a 100 effects for users ... images in 3-D. , Founder Paul Falstad said that ... it has real-time view so users can try out any ...
(Date:3/31/2015)... St. Louis, MO (PRWEB) March 31, 2015 ... April 8, 2015 from 5:00 to 8:00 pm at the ... than 50 hospitals, clinics and groups with career opportunities will ... represented. Attendees will enjoy free hors d’oeuvres and raffle prize ... PracticeMatch says “Denver is an ideal location to hold ...
Breaking Medicine News(10 mins):Health News:Trial Shows Stem Cells Provide Long-Term Relief from Dangerous Crohn’s Side Effect 2Health News:Mesothelioma Foundation to speak at BoRit Asbestos Superfund Citizen Advisory Group Meeting 2Health News:PharmMD Places Victor Mattingly in C-Suite, Company Focused on Medication Therapy Management and Part D Star Ratings 2Health News:New Mega Photo App Launched and Provides the Ultimate Playground for Photos 2Health News:PracticeMatch to Host Physician Career Fair at SpringHill Suites Denver on April 8, 2015 2Health News:PracticeMatch to Host Physician Career Fair at SpringHill Suites Denver on April 8, 2015 3
... ... ... , ... , , , ...
... workshop have been released to address deep-vein thrombosis (DVT) ... estimated to affect nearly 1 million Americans each year. ... representatives from federal health agencies and patient groups, as ... communities appear in the March 9, 2010, ...
... a successful relationship partners shouldn,t go to bed angry. ... that brain activityspecifically in the region called the lateral prefrontal ... in the days following a fight with his or her ... lateral prefrontal cortex are less likely to be upset the ...
... oophorectomy) while performing a hysterectomy is common practice to ... procedure is performed in 55 percent of all US ... year. An article in the March/April issue of t ... ovaries (bilateral oophorectomy) while performing a hysterectomy is common ...
... anxiety, depression and stress lessened, researchers say , TUESDAY, March ... psychological woes in patients with lupus who have high levels ... also helps these patients improve and maintain their quality of ... included 45 patients randomly assigned to a control group or ...
... ... only seven one-hundredths of one percent of the products manufactured by the company. , ... Dinuba, CA (Vocus) March 9, 2010 ... potential salmonella exposure. To date, no salmonella-related illnesses have been reported in conjunction to ...
Cached Medicine News:Health News:South Dakota Students with Asthma Can Breathe Easier After New Law Allows Self-Administered Medications 2Health News:Critical recommendations unveiled: Deep-vein thrombosis and pulmonary embolism 2Health News:Critical recommendations unveiled: Deep-vein thrombosis and pulmonary embolism 3Health News:After a fight with a partner, brain activity predicts emotional resiliency 2Health News:New study questions benefits of elective removal of ovaries during hysterectomy 2
PremierEdge™ Stab Knives - 45°....
PremierEdge™ Stab Knives - 30°....
PremierEdge™ Stab Knives - 22.5°....
Lacrimal Intubation Set w/Retrieval Device. Size: Probes 23g x 4-1/4"....
Medicine Products: